Merck KGaA Forecasts Modest Profit Growth Amid Market Recovery

Merck KGaA, a prominent player in the pharmaceutical and chemicals industry, has projected a slow but steady profit growth for the current fiscal year. This anticipated growth comes as the company navigates the recovery phase following the impact of the pandemic on global markets. The firm’s leaders stress that while the outlook remains cautious, positive developments are on the horizon.

Continue reading